TG Therapeutics (TGTX)
(Delayed Data from NSDQ)
$25.28 USD
+0.03 (0.12%)
Updated Sep 19, 2024 03:59 PM ET
After-Market: $25.28 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth D Momentum D VGM
Industry / Sector Report
Industry : Medical - Products
Zacks Industry Rank
Top 26% (65 out of 251)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.63 | 1.70 | 9.99 |
Current Quarter Estimate | 0.03 | 7.55 | 61.00 |
Year Ago Quarter Estimate | 0.73 | 4.52 | 54.84 |
Next Quarter Estimate | 0.09 | 8.55 | 63.00 |
Next Year Estimate | 0.83 | 45.18 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 44.44 | 13.00 | 15.67 |
Next Year | 538.46 | 22.80 | 11.34 |
Last 5 Years | NA | 2.90 | 8.10 |
Next 5 Years | NA | 15.90 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 41.39 | 5.81 |
Price/Book (MRQ) | 21.98 | 2.18 |
Price/Cash Flow (MRFY) | 288.82 | 11.77 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | 27.60% | -9.36% |
Return on Equity (TTM) | 57.73% | -3.53% |
Debt to Equity (MRQ) | 0.58 | 23.08 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.